OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
Melissa Talita Wiprich, Carla Denise Bonan
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Melissa Talita Wiprich, Carla Denise Bonan
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Showing 17 citing articles:
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 63
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 63
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington’s disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway
Weam W. Ibrahim, Nora O. Abdel Rasheed
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1745-1758
Open Access | Times Cited: 30
Weam W. Ibrahim, Nora O. Abdel Rasheed
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1745-1758
Open Access | Times Cited: 30
The P2X7 receptor as a new pharmacological target for retinal diseases
Chiara Bianca Maria Platania, Filippo Drago, Claudio Bucolo
Biochemical Pharmacology (2022) Vol. 198, pp. 114942-114942
Closed Access | Times Cited: 23
Chiara Bianca Maria Platania, Filippo Drago, Claudio Bucolo
Biochemical Pharmacology (2022) Vol. 198, pp. 114942-114942
Closed Access | Times Cited: 23
6-shogaol against 3-Nitropropionic acid-induced Huntington’s disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway
Ebtihaj J. Jambi, Abdulaziz Alamri, Muhammad Afzal, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305358-e0305358
Open Access | Times Cited: 4
Ebtihaj J. Jambi, Abdulaziz Alamri, Muhammad Afzal, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305358-e0305358
Open Access | Times Cited: 4
Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington’s disease
Amit Shiwal, Dhanshree Nibrad, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access
Amit Shiwal, Dhanshree Nibrad, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access
Olfactory Dysfunction in Huntington’s Disease
Jorge Patiño, Nicholas E. Karagas, Shivika Chandra, et al.
Journal of Huntington s Disease (2021) Vol. 10, Iss. 4, pp. 413-422
Open Access | Times Cited: 16
Jorge Patiño, Nicholas E. Karagas, Shivika Chandra, et al.
Journal of Huntington s Disease (2021) Vol. 10, Iss. 4, pp. 413-422
Open Access | Times Cited: 16
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
Mona E Noureldeen, Nancy N. Shahin, Hebat Allah A. Amin, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Mona E Noureldeen, Nancy N. Shahin, Hebat Allah A. Amin, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease
Pradeep Singh, Garima Mishra, Mulugeta Molla, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105047-105047
Open Access | Times Cited: 10
Pradeep Singh, Garima Mishra, Mulugeta Molla, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105047-105047
Open Access | Times Cited: 10
Inflammasome activation and assembly in Huntington’s disease
Tiago de Oliveira Furlam, Isadora Gonçalves Roque, Ewelin Wasner Machado da Silva, et al.
Molecular Immunology (2022) Vol. 151, pp. 134-142
Closed Access | Times Cited: 10
Tiago de Oliveira Furlam, Isadora Gonçalves Roque, Ewelin Wasner Machado da Silva, et al.
Molecular Immunology (2022) Vol. 151, pp. 134-142
Closed Access | Times Cited: 10
G protein‐coupled receptor‐mediated autophagy in health and disease
Devrim Öz Arslan, Zeynep A. Oztug Durer, Beki Kan
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Devrim Öz Arslan, Zeynep A. Oztug Durer, Beki Kan
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Pharmacology of natural bioactive compounds used for management of Huntington Diseases: An overview
Dipak Dilipkumar Gadade, Rashmi Sareen, Nitin Jain, et al.
Brain Behavior and Immunity Integrative (2024) Vol. 8, pp. 100091-100091
Open Access | Times Cited: 1
Dipak Dilipkumar Gadade, Rashmi Sareen, Nitin Jain, et al.
Brain Behavior and Immunity Integrative (2024) Vol. 8, pp. 100091-100091
Open Access | Times Cited: 1
Effect of Quinolinic Acid on Behavior, Morphology, and Expression of Inflammatory/oxidative Status in Rats’ Striatum: Is Coenzyme Q10 a Good Protector?
Fernanda Silva Ferreira, Osmar Vieira Ramires, Tiago Marcon dos Santos, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 6, pp. 559-570
Closed Access | Times Cited: 2
Fernanda Silva Ferreira, Osmar Vieira Ramires, Tiago Marcon dos Santos, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 6, pp. 559-570
Closed Access | Times Cited: 2
The promise of an underappreciated therapeutic target: Sleep and circadian rhythm dysfunction in Huntington's disease
Christopher S. Colwell, Weiyi Tan, A. Jennifer Morton
Elsevier eBooks (2024), pp. 499-521
Closed Access
Christopher S. Colwell, Weiyi Tan, A. Jennifer Morton
Elsevier eBooks (2024), pp. 499-521
Closed Access
Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms
Madhuri Suma Jakkamsetti, Aravinda Sai Kolusu, Suma Rongala, et al.
NeuroToxicology (2024) Vol. 105, pp. 131-146
Closed Access
Madhuri Suma Jakkamsetti, Aravinda Sai Kolusu, Suma Rongala, et al.
NeuroToxicology (2024) Vol. 105, pp. 131-146
Closed Access
Neuroprotective Effect of Ethanolic Extract of Pedalium murex Linn Leaf in 3-Nitropropionic acid Induced Neurodegeneration
Suresh Velayutham, Arunprasanth Sundararaju, Thamotharan GOVINDHASWAMY, et al.
Journal of Research in Pharmacy (2023) Vol. 27(3), Iss. 27(3), pp. 1143-1156
Open Access
Suresh Velayutham, Arunprasanth Sundararaju, Thamotharan GOVINDHASWAMY, et al.
Journal of Research in Pharmacy (2023) Vol. 27(3), Iss. 27(3), pp. 1143-1156
Open Access
Neuroprotective Effect of Ethanolic Extract of Pedalium murex Linn Leaf in 3-Nitropropionic acid Induced Neurodegeneration
Suresh Velayutham, Arunprasanth Sundararaju, Thamotharan GOVINDHASWAMY, et al.
Journal of Research in Pharmacy (2023) Vol. 27(4), Iss. 27(4), pp. 1388-1401
Open Access
Suresh Velayutham, Arunprasanth Sundararaju, Thamotharan GOVINDHASWAMY, et al.
Journal of Research in Pharmacy (2023) Vol. 27(4), Iss. 27(4), pp. 1388-1401
Open Access
